SARS genome patent: Symptom or disease?

Lancet

Volumn 361, Issue 9374, 2003, Pages 2002-2003

  Gold, E Richard ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENOME; GENOMICS; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MOLECULAR GENETICS; NOTE; PATENT; PRIORITY JOURNAL; PUBLISHING; RESPIRATORY TRACT INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 0038177830     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13674-4     Document Type: Note

References (10)

1. Brickley P. Preemptive SARS patents: U.S. and Canadian agencies say patents will preserve access. The Scientist, May 9, 2003: http://www.biomedcentral.com/news/20030509/02 (accessed May 27, 2003).
2. Gold E.R. Merging business and ethics: new models for using biotechnological intellectual property in genetically modified foods. Castle D., Ruse M. Debating biotechnology. 2002;163-181 Prometheus Press, New York.
3. Gold E.R. Making room: reintegrating basic research, health policy, and ethics into patent law. Caulfield T.A., Williams-Jones B. The commercialization of genetic research: ethical, legal, and policy issues. 1999;63-78 Kluwer Academic/Plenum Publishers, New York.
4. Cho M.K., Illangaskekare S., Weaver M.A., Leonard D.G.B., Merz J.F. Effects of patents and licenses on the provision of clinical genetic testing services. J Molec Diagn. 5:2003;3-8.
5. Merz J.F., Kriss A.G., Leonard D.G.B., Cho M.K. Diagnostic testing fails the test: the pitfalls of patents are illustrated by the case of haemochromatosis. Nature. 415:2002;577-579.
6. Ministry of Health and Long-term Care, Government of Ontario, Canada. Genetics, testing & gene patenting: charting new territory in healthcare. January, 2002: http://www.health.gov.on.ca/english/public/pub/ ministry_reports/geneticsrep02/genetics.html (accessed June 10, 2003).
7. Gold E.R., Caulfield T., Ray P. Gene patents and the standard of care. CMAJ. 167:2002;256-257.
8. Organisation for Economic Co-operation and Development. Genetic inventions, intellectual property rights and licensing practices: evidence and policies. Paris: OECD, 2002.
9. Gold E.R. Biotechnology patents: strategies for meeting economic and ethical concerns. Nat Genet. 30:2002;359.
10. Gold E.R., Caulfield T.A. The moral tollbooth: a method that makes use of the patent system to address ethical concerns in biotechnology. Lancet. 350:2002;2268-2270.